Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm
Open accessThe DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Many ascomycete yeast species from the Candida genus are widely distributed in nature and act as common saprophytic constituents of the normal human microflora. However, some of these fungal species can also become opportunistic pathogens following a transition from a commensal to a pathogenic phase, induced by alterations in the host environment. Candida species thereby rarely trigger infection in healthy people, but take advantage of a locally or systematically impaired immune system to proliferate in the host and cause diseases termed ‘‘candidiasis.’’ Such fungal infections can be subdivided into three major groups: cutaneous (skin and its appendages), mucosal (oropharyngeal, esophageal, and vulvovaginal) and systemic (bloodstream infections, i.e., candidemia and other forms of invasive candidiasis [IC]). While superficial candidiasis (cutaneous and mucosal) is often observed in AIDS patients, oropharyngeal thrush and vaginitis are more frequently seen in immunocompetent infants and adult women, respectively. Candidemia and IC are common in cancer patients or in transplant individuals following immunosuppression. Candidiasis currently represents the fourth leading cause of nosocomial infections, at 8% to 10%, and mortality due to systemic candidiasis remains high, ranging from 15% to 35% depending on the infecting Candida species [1]. Although Candida albicans remains the most frequently isolated agent of candidiasis, non-albicans Candida (NAC) species now account for a substantial part of clinical isolates collected worldwide in hospitals. NAC species of particular clinical importance include Candida glabrata, Candida tropicalis, Candida parapsilosis, and Candida krusei (synonym: Issatchenkia orientalis), as well as the less-prominent species Candida guilliermondii, Candida lusitaniae, Candida kefyr, Candida famata (synonym: Debaryomyces hansenii), Candida inconspicua, Candida rugosa, Candida dubliniensis, and Candida norvegensis (Table 1). A complementary set of about 20 opportunistic NAC species is also known, but exhibits lower isolation rates [2].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to C. auris, which truly is an emerging pathogen, Candida spp. that were defined before as “emerging”77 (ie, C. kefyr, C. guilliermondii, C. lusitaniae, C. dubliniensis, C. famata, C. inconspicua, C. rugosa, C. norvegiensis), may have in fact already “emerged” due to better diagnostic differentiation methods, or were selected by the broad use of antifungal treatment and prophylaxis.”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“Candidiasis currently represents the fourth leading cause of nosocomial infections, at 8% to 10%, and mortality due to systemic candidiasis remains high, ranging from 15% to 35% depending on the infecting Candida species [1].”
BackgroundEvolution of pathogenicity and sexual reproduction in eight Candida genomes
Butler, G., Rasmussen, M. D., Lin, M. F., Santos, M. A. S., Sakthikumar, S., Munro, C. A., Rheinbay, E., Grabherr, M., Forche, A., Reedy, J. L., et al. (2009) · Nature · doi:10.1038/nature08064 · Cited by 1,065 · cited 1×
“These genome resources have provided new insights into gene family evolution within Candida species and identified gene families enriched in the most common pathogenic NAC species [21].”
BackgroundSilva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00278.x · Cited by 969
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
The diploid genome sequence of Candida albicans
Jones, T., Federspiel, N. A., Chibana, H., Dungan, J., Kalman, S., Magee, B. B., Newport, G., Thorstenson, Y. R., Agabian, N., Magee, P. T., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401648101 · Cited by 768
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718 · cited 6×
“norvegensis, although rarely isolated, are now considered emerging NAC species, as their isolation rate has increased between 2- and 10-fold over the last 15 years [2].”
BackgroundInfluentialA fungal phylogeny based on 42 complete genomes derived from supertree and combined gene analysis.
(2006) · BMC Evolutionary Biology · doi:10.1186/1471-2148-6-99 · Cited by 475
Fanning, S., & Mitchell, A. P. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002585 · Cited by 465 · cited 1×
“albicans from the end of the 20 century shed light on the molecular mechanisms involved in drug resistance [11], biofilm formation [12], adherence [13], yeasthyphal switching and its role in virulence [14], and sexual mating [15,16].”
BackgroundEvidence for Mating of the "Asexual" Yeast Candida albicans in a Mammalian Host
Hull, C. M., Raisner, R. M., & Johnson, A. D. (2000) · Science · doi:10.1126/science.289.5477.307 · Cited by 460
Cited by
The Candida Pathogenic Species Complex
Turner, S. A., & Butler, G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019778 · Cited by 336
Immune defence to invasive fungal infections: A comprehensive review
Pathakumari, B., Liang, G., & Liu, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110550 · Cited by 264
Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris
Chatterjee, S., Alampalli, S. V., Nageshan, R. K., Chettiar, S. T., Joshi, S., & Tatu, U. S. (2015) · BMC Genomics · doi:10.1186/s12864-015-1863-z · Cited by 247
“Recently invasive non albicans candidiasis cases have been reported from many parts of the world [8–11].”
Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth
Haque, F., Alfatah, M., Ganesan, K., & Bhattacharyya, M. S. (2016) · Scientific Reports · doi:10.1038/srep23575 · Cited by 189
Molecular diagnostics in medical mycology
Wickes, B. L., & Wiederhold, N. P. (2018) · Nature Communications · doi:10.1038/s41467-018-07556-5 · Cited by 188
Metadata
- Authors
- Papon, N., Courdavault, V., Clastre, M., & Bennett, R. J.
- Affiliations
- Université de Tours (FR)
- Brown University (US)
- Corresponding author
- Papon, Nicolas
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-26
- Volume
- 9
- Issue
- 9
- Pages
- e1003550
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3784480
- OpenAlex
- W2080591858
- Cited by
- 314
- References
- 28
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 24 · 2023: 25 · 2022: 27 · 2021: 36 · 2020: 20 · 2019: 30 · 2018: 29 · 2017: 23 · 2016: 31 · 2015: 18 · 2014: 20 · 2013: 1
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Essex
- Broad Institute
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- non-albicans Candida, Candida albicans, candidiasis, invasive candidiasis, candidemia, opportunistic fungal pathogens, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, Candida guilliermondii, Candida lusitaniae, Candida kefyr, Debaryomyces hansenii, Candida inconspicua, Candida rugosa, Candida dubliniensis, Candida norvegensis, cutaneous candidiasis, mucosal candidiasis, vaginal candidiasis, nosocomial infections, immunocompromised patients, commensal to pathogen transition
- MeSH terms
- Animals, Candida albicans, Candidiasis, Humans, Communicable Diseases, Emerging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm. https://app.cochat.ai/papers/10.1371/journal.ppat.1003550
- The paper
- Papon, N., Courdavault, V., Clastre, M., & Bennett, R. J. (2013). Emerging and Emerged Pathogenic Candida Species: Beyond the Candida albicans Paradigm. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1003550
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.